Milton Mutchnick, MD
Gastroenterology · Detroit, MINPI 1407894579
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $89,989 of the $106,053 with a category attached, or 84.9%. 17 manufacturers reported payments, led by Gilead at 53.7% of the total. Reporting peaked in 2019 at $45,741 and has fallen 76.9% since, to $10,549 in 2025. Among gastroenterology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 295 payments — averaging $359.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$57K
- Intercept Pharmaceuticals, Inc.$23K
- AbbVie$15K
- Madrigal Pharmaceuticals$10K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$673
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$118
- plus $505 from 11 others
Across 63 payments — averaging $2449.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch Health US, LLC$75K
- Janssen Research & Development, LLC$54K
- Gilead$21K
- Exact Sciences$4K
What the payments were for
- Speaking & faculty fees$89,98985%
- Travel & lodging$8,7768%
- Food & beverage$7,2887%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 140 | $56,937 |
| Intercept Pharmaceuticals, Inc. | 22 | $22,547 |
| AbbVie | 78 | $15,082 |
| Madrigal Pharmaceuticals | 16 | $10,192 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $673 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $118 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $111 |
| Ardelyx, Inc. | 6 | $95 |
| GSK | 1 | $57 |
| QOL Medical, LLC | 3 | $52 |
| Johnson & Johnson | 3 | $43 |
| Nestle Healthcare Nutrition Inc. | 3 | $39 |
| Bristol Myers Squibb | 2 | $34 |
| Smith+Nephew | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| Novo Nordisk | 1 | $18 |
| Sanofi | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$106,053 in reported general payments places this provider in the 95th percentile of 497 gastroenterology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Detroit
- Kimberly BrownDetroit$733K
- Dilip MoonkaDetroit$611K
- Stuart GordonDetroit$178K
- Reena SalgiaDetroit$112K
- Sumit SinglaDetroit$76K
- Nirmal KaurDetroit$59K
- Humberto Gonzalez GonzalezDetroit$53K
- Tobias ZuchelliDetroit$39K
- Juan Reyes GenereDetroit$37K
- Brian GinnebaughDetroit$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.